This inventor holds 1 USPTO granted patent. Top assignee: Darwin Discovery Limited. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Elizabeth Jane Reed Nicholson
Introduction
Elizabeth Jane Reed Nicholson is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. Her work focuses on the inhibition of matrix metalloproteinases (MMP) and tumor necrosis factor (TNF), which are crucial in various disease processes.
Latest Patents
Elizabeth holds a patent for "Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity." This patent includes compounds of formula (I) that demonstrate promising biological activity. Her innovative approach in this area highlights her commitment to advancing medical science.
Career Highlights
Elizabeth is currently associated with Darwin Discovery Limited, where she continues to explore new avenues in drug discovery and development. Her expertise in medicinal chemistry has positioned her as a valuable asset in her field.
Collaborations
Throughout her career, Elizabeth has collaborated with esteemed colleagues, including Andrew Douglas Baxter and David Alan Owen. These partnerships have fostered a dynamic research environment, leading to impactful scientific advancements.
Conclusion
Elizabeth Jane Reed Nicholson's contributions to medicinal chemistry and her innovative patent reflect her dedication to improving health outcomes. Her work continues to inspire future research in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile